| Title: |
Toxigenic Clostridium difficile Infection in Children: Performance of Toxin A/B Immunoassay. |
| Authors: |
Mardaneh, Jalal; Mohammadzadeh, Alireza; Bagheri, Saeede; Baniasadi, Maryam; Yousefi, Masoud; Pouladfar, Gholamreza; Anvarinejad, Mojtaba |
| Source: |
Crescent Journal of Medical & Biological Sciences; Apr2021, Vol. 8 Issue 2, p122-126, 5p |
| Subject Terms: |
CLOSTRIDIOIDES difficile; PERFORMANCE in children; TOXINS; IMMUNOASSAY; MEDICAL microbiology; ACTINOBACILLUS actinomycetemcomitans |
| Abstract: |
Objectives: Clostridium difficile is a major nosocomial pathogen that infects the large intestine (colon) and causes a range of clinical manifestations from mild to severe diarrhea. The aim of this study was to assess the detection of pathogenic toxin A/Bpositive C. difficile strains among hospitalized patients with diarrhoea in Gonabad, Iran. Materials and Methods: In this cross-sectional study, hospitalized patients submitted to 22 Bahman Hospital (Gonabad, Iran) were included if they had a liquid stool specimen. From November 2016 through July 2017, a total of 50 sequential stool samples (unformed or liquid) were obtained from hospitalized patients for inclusion in this study. The stool samples were collected and C. difficile toxin A/B immunoassay was performed according to the manufacturer's guidelines. Results: Based on the results, the maximum number of cases belonged to the age group of less than 10 years (n=29, 58%). Most studied patients were hospitalized in the pediatrics ward (n=24, 48%). Among the studied patients, 16 (32%) cases were positive for C. difficile toxin A/B by immunochromatographic assay. Frothy-four (88%) patients received one or more antibiotic treatment on admission and hospitalization. Ceftriaxone was the most common applied drug for the treatment of these patients. Finally, 5 (31.25%) patients received combination therapy. Overall, 34.48% of pediatric cases were positive for C. difficile toxin A/B. Conclusions: Our results showed that the emergence of potentially highly virulent and antibiotic-resistant C. difficile isolates is alarming. The diagnostic of pathogenic C. difficile by the clinical microbiology laboratory can improve the handling of disease and more reasonable use of antimicrobials by the physician. [ABSTRACT FROM AUTHOR] |
| : |
Copyright of Crescent Journal of Medical & Biological Sciences is the property of Aras Part Medical International Press and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |